Align Technology (NASDAQ:ALGN) shares surged more than 12% after-hours following the company’s reported Q2 results, with EPS of $2.22 coming in better than the consensus estimate of $2.04. Revenue grew 3.3% year-over-year to $1 billion, beating the consensus estimate of $992.76 million.
Q2 Clear Aligner revenues grew 4.3% year-over-year to $832.7M, with Clear Aligner volume of 604,400 cases, representing a 0.9% year-over-year increase.
For Q3/23, the company expects revenue in the range of $990M-1.01B, compared to the consensus of $990M. For the full year, the company sees revenue in the range of $3.97-3.99B, compared to the consensus of $3.94 billion.